A detailed history of Hilltop National Bank transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Hilltop National Bank holds 20 shares of VRTX stock, worth $10,049. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20
Holding current value
$10,049
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$460.0 - $505.78 $9,200 - $10,115
20 New
20 $9.3 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Hilltop National Bank Portfolio

Follow Hilltop National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hilltop National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Hilltop National Bank with notifications on news.